A Hierarchical Bayesian Design for Phase I Trials of Novel Combinations of Cancer Therapeutic Agents (Q3064270): Difference between revisions

From MaRDI portal
Created claim: Wikidata QID (P12): Q41241253, #quickstatements; #temporary_batch_1712688784189
ReferenceBot (talk | contribs)
Changed an Item
 
Property / cites work
 
Property / cites work: Designs for Single- or Multiple-Agent Phase I Trials / rank
 
Normal rank
Property / cites work
 
Property / cites work: Statistical properties of the traditional algorithm-based designs for phase I cancer clinical trials / rank
 
Normal rank
Property / cites work
 
Property / cites work: Continual Reassessment Method for Ordered Groups / rank
 
Normal rank
Property / cites work
 
Property / cites work: Continual Reassessment Method: A Likelihood Approach / rank
 
Normal rank
Property / cites work
 
Property / cites work: Continual Reassessment Method: A Practical Design for Phase 1 Clinical Trials in Cancer / rank
 
Normal rank
Property / cites work
 
Property / cites work: Q4267796 / rank
 
Normal rank
Property / cites work
 
Property / cites work: Design and Analysis of Phase I Clinical Trials / rank
 
Normal rank
Property / cites work
 
Property / cites work: Dose-Finding with Two Agents in Phase I Oncology Trials / rank
 
Normal rank
Property / cites work
 
Property / cites work: Two‐Dimensional Dose Finding in Discrete Dose Space / rank
 
Normal rank

Latest revision as of 14:45, 3 July 2024

scientific article
Language Label Description Also known as
English
A Hierarchical Bayesian Design for Phase I Trials of Novel Combinations of Cancer Therapeutic Agents
scientific article

    Statements

    A Hierarchical Bayesian Design for Phase I Trials of Novel Combinations of Cancer Therapeutic Agents (English)
    0 references
    0 references
    0 references
    0 references
    21 December 2010
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    adaptive design
    0 references
    Bayesian statistics
    0 references
    dose-escalation study
    0 references
    dose-finding study
    0 references
    two dimensional
    0 references
    0 references
    0 references